Titlebook: Oncology in the Precision Medicine Era; Value-Based Medicine Ravi Salgia Book 2020 Springer Nature Switzerland AG 2020 oncology.cancer.prec

Systemic

ACME

Lung Cancer,n tumor type, demonstrating molecular connections between diverse tumors. Immunotherapy in lung cancer has also redefined treatment paradigms for patients with lung cancer. Initially, single-agent treatment with programmed death 1 (PD-1) and programmed death receptor ligand 1 (PD-L1) antibodies demo

偏見

Multiple Myeloma,er tandem transplantations are of significant benefit. Moreover, allogeneic transplantations yield relatively high transplant-related mortality rates and uncertain benefit over ASCT and therefore is not widely performed. In relapsed disease, disease-related, patient-related, and treatment-related pa

FUSE

Colon Cancer,ducing new agents despite several well-done trials conducted in the United States and Europe. We have to revisit as a scientific community the use of the metastatic setting as a predictive environment for the adjuvant setting. We have, however, been able to reduce the intensity of existing therapies

Euthyroid

Genomic Cancer Risk Assessment,gnition of potential germline genomic information in the context of tumor analyses for precision medicine. The scope of knowledge, tools, and expertise required for practitioner-level competence in genomic counseling is summarized and highlights the need for genetics and genomics professional educat

極深

Triple-Negative Breast Cancer,ents still face increased risk of early metastasis and death from TNBC (Anders and Carey. Clin Breast Cancer 9:S73–S81, 2009). In the metastatic setting following first-line treatment, median overall survival is 6–13?months, and medial progression-free survival (PFS) is 3–4?months (Kassam et al. Cli

ironic

Digital Patient Engagement and Social Media,, research reports, state of the science papers, position papers, and clinical guidelines from professional organizations, the primary purpose of this chapter is to describe the current use of digital patient engagement and social media use in oncology care, and to describe evidence-based informatio

擴(kuò)大

內(nèi)部

寡頭政治